REFERENCES
- Xu G., Zhang W., Ma M. K., McLeod H. L. Human carboxylesterase 2 is commonly expressed in tumor tissue and is correlated with activation of irinotecan. Clin. Cancer Res. 2002; 8: 2605–2611
- Guichard S., Terret C., Hennebelle I., Lochon I., Chevreau P., Fretigny E. Irinotecan converting carboxylesterase and topoisomerase activities in tumor and normal colon and liver tissues. Br. J. Cancer. 1999; 80: 364–370
- Sanghani S. P., Quinney S. K., Fredenburg T. B., Sun Z., Davis W. I., Murry D. J., et al. Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis. Clin Cancer Res. 2003; 9: 4983–4991
- Gao J., Gao Y., Ju Y., Yang J., Wu Q., Zhang J., et al. Proteomics-based generation and characterization of monoclonal antibodies against human liver mitochondrial proteins. Proteomics. 2005; 1–11
- Wu Z., Tang X., Wang Z., Ji H., Yu L., Liu H., Zhu D. Preparation and characterization of monoclonal antibody against human carboxylesterase 2. Cell J. and Molecular Immunology 2007; 23: 148–151
- Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Bio. 1976; 72: 248–254
- Danks M. K., Morton C. L., Krull E. J., Cheshire P. J., Richmond L. B., Naeve C. W. et al. Comparison of activation of irinotecan by rabbit and human carboxylesterase for use in enzyme/prodrug therapy. Clin Cancer Res. 1999; 5: 917–924
- Khanna R., Morton C. L., Danks M. K., Potter P. M. Proficient metabolism of iriotecan by a human intestinal carboxylesterase. Cancer Res. 2000; 60: 4725–4728
- Humerickhouse R., Lohrbach K., Li L., Borson W. F., Dolan M. E. Characterization of irinotecan hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2. Cancer Res. 2000; 60: 1189–1192
- Potter P. M., Wolverton J. S., Morton C. L., Whipple D. O., Danks M. K. In situ subcellular localization of epitope-tagged human and rabbit carboxylesterase. Cytometry. 1998; 32: 223–232
- Satoh T., Hosokawa M., Atsumi R., Suzuki W., Hakusui H., Nagai E. Metabolic activation of CPT-11, 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin, a novel antitumor agent, by carboxylesterase. Biol Pharm Bull. 1994; 17: 662–664
- Yan B., Matoney L., Yang D. Human carboxylesterases in term placenta: enzymatic characterization, molecular cloning and evidence for the existence of multiple forms. Placenta. 1999; 20: 599–607